Michael Petusky
Stock Analyst at Barrington Research
(3.39)
# 1,034
Out of 4,479 analysts
102
Total ratings
47.92%
Success rate
2.5%
Average return
Main Sectors:
14 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SRDX Surmodics | Downgrades: Market Perform | n/a | $41.97 | - | 6 | May 30, 2024 | |
VRME VerifyMe | Maintains: Outperform | $2 → $1.7 | $1.32 | +28.79% | 6 | May 24, 2024 | |
HAE Haemonetics | Maintains: Outperform | $105 → $107 | $83.12 | +28.73% | 14 | May 10, 2024 | |
ANIK Anika Therapeutics | Maintains: Outperform | $37 | $25.90 | +42.86% | 8 | May 9, 2024 | |
USPH U.S. Physical Therapy | Maintains: Outperform | $122 | $92.27 | +32.22% | 11 | May 9, 2024 | |
HSIC Henry Schein | Maintains: Outperform | $90 → $92 | $65.67 | +40.09% | 7 | May 8, 2024 | |
LMAT LeMaitre Vascular | Maintains: Outperform | $69 → $79 | $81.09 | -2.58% | 5 | May 3, 2024 | |
XRAY DENTSPLY SIRONA | Maintains: Outperform | $41 → $38 | $24.62 | +54.38% | 11 | May 3, 2024 | |
MMSI Merit Medical Systems | Maintains: Outperform | $98 → $100 | $86.89 | +15.09% | 10 | May 1, 2024 | |
OPCH Option Care Health | Maintains: Outperform | $38 | $27.60 | +37.71% | 7 | Apr 24, 2024 | |
OPK OPKO Health | Maintains: Outperform | $1.5 | $1.22 | +23.46% | 4 | Apr 1, 2024 | |
MODV ModivCare | Downgrades: Market Perform | n/a | $27.33 | - | 7 | Feb 26, 2024 | |
LFCR Lifecore Biomedical | Maintains: Outperform | $11 → $10 | $4.59 | +118.10% | 5 | Sep 1, 2023 | |
ATIP ATI Physical Therapy | Downgrades: Market Perform | n/a | $4.89 | - | 1 | Jul 27, 2021 |
Surmodics
May 30, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $41.97
Upside: -
VerifyMe
May 24, 2024
Maintains: Outperform
Price Target: $2 → $1.7
Current: $1.32
Upside: +28.79%
Haemonetics
May 10, 2024
Maintains: Outperform
Price Target: $105 → $107
Current: $83.12
Upside: +28.73%
Anika Therapeutics
May 9, 2024
Maintains: Outperform
Price Target: $37
Current: $25.90
Upside: +42.86%
U.S. Physical Therapy
May 9, 2024
Maintains: Outperform
Price Target: $122
Current: $92.27
Upside: +32.22%
Henry Schein
May 8, 2024
Maintains: Outperform
Price Target: $90 → $92
Current: $65.67
Upside: +40.09%
LeMaitre Vascular
May 3, 2024
Maintains: Outperform
Price Target: $69 → $79
Current: $81.09
Upside: -2.58%
DENTSPLY SIRONA
May 3, 2024
Maintains: Outperform
Price Target: $41 → $38
Current: $24.62
Upside: +54.38%
Merit Medical Systems
May 1, 2024
Maintains: Outperform
Price Target: $98 → $100
Current: $86.89
Upside: +15.09%
Option Care Health
Apr 24, 2024
Maintains: Outperform
Price Target: $38
Current: $27.60
Upside: +37.71%
OPKO Health
Apr 1, 2024
Maintains: Outperform
Price Target: $1.5
Current: $1.22
Upside: +23.46%
ModivCare
Feb 26, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $27.33
Upside: -
Lifecore Biomedical
Sep 1, 2023
Maintains: Outperform
Price Target: $11 → $10
Current: $4.59
Upside: +118.10%
ATI Physical Therapy
Jul 27, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $4.89
Upside: -